Go to Page # Page of 27

Pharma Needs: Go No-Go Decisions in Therapeutic Drug Development

 Diane Jorkasky, MD, FACP
Description: Worst year in history for Pharma: – Rising R&D Costs – Declining productivity…… declining creativity? – Uncertain pipelines – big risks, exceptional failures – Increasing regulatory conservatism – Financial instability impacting all investment – Conflict of interest impacts and yet… …..no more important time for academia and industry to work together – to develop new therapeutic agents. Should we embark on this biological target? What are Pharma’s needs in therapeutic drug development?
Views: 3493
Domain: Medical
Category: Biotech/Pharma
Pharma needs: Go No-Go Decisions in Therapeutic Drug Development
Diane Jorkasky, MD, FACP Independent Consultant (Retired from Pfizer Global Research & Development) February 8, 2009 Society of Nuclear Medicine


Why am I here?
� � � nephrologist, clinical pharmacology early development x 23 years former chair, Yale / Pfizer Imaging Alliance in PET technology ... See more

Recent Presentations

Impact of Clinician Burnout on Patient Safety

Main objective is to identify strategies for improving well-being & resilience in the healthcare workforce. Explain, clinician burnout is a patient care & healthcare workforce prob

Paul Abramowitz
27 June, 2019

Innovation in Allergy Immunotherapy

ASIT biotech treatments consist of a mixture of purified peptides from different selected sizes, produced from natural sources of allergens for allergy immunotherapy.

26 June, 2019
Bionure Farma
25 June, 2019